JRNL Inc. – Trademark Portfolio

Entity Type: 03

JRNL Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 7 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include LDSJOURNAL and LIFE IS WORTH RECORDING. The owner is based in Las Vegas, NV.

7435 S. Eastern #264

Las Vegas, NV 89123

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

JRNL Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (7 filings)

Scientific and technological services; industrial analysis and research services

36
Insurance & Financial (1 filing)

Insurance; financial affairs; monetary affairs; real estate affairs

38
Telecommunications (1 filing)

Telecommunications

Frequently Asked Questions

How many trademarks does JRNL Inc. have?

JRNL Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 6 cancelled.

What trademark classes does JRNL Inc. file in?

JRNL Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.

What are JRNL Inc.'s most well-known trademarks?

JRNL Inc.'s registered trademark portfolio includes well-known marks such as LDSJOURNAL and LIFE IS WORTH RECORDING. These are among 2 currently registered trademarks in the portfolio.

What is JRNL Inc.'s trademark registration success rate?

JRNL Inc. has a 22% trademark registration rate, with 2 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.